• Nutex Health's nine-month net income rose to $152.9 million from $59 million through September 30, 2026, an investor presentation showed.
• Adjusted EBITDA totaled $211.4 million versus $243 million a year earlier, including a $52.3 million noncash reduction in contract services expense.
• Hospital visits increased 10.2% to 154,326, with same-hospital visits up 6.3%.
• Operating cash flow reached $188.1 million, compared with $177.7 million a year earlier.
• Cash and cash equivalents totaled $249.9 million, up from $185.6 million at December 31, 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nutex Health Inc. published the original content used to generate this news brief on November 09, 2026, and is solely responsible for the information contained therein.